CB2 receptor agonist 2
CAS No. 1314230-75-5
CB2 receptor agonist 2( 4-Quinolone-3-Carboxamide Furan CB2 Agonist | ZINC72105556 )
Catalog No. M27495 CAS No. 1314230-75-5
CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 267 | Get Quote |
|
| 5MG | 422 | Get Quote |
|
| 10MG | 618 | Get Quote |
|
| 25MG | 972 | Get Quote |
|
| 50MG | 1305 | Get Quote |
|
| 100MG | 1764 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCB2 receptor agonist 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.
-
DescriptionCB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.(In Vitro):CB2 receptor agonist 2 (compound 4g) (1 μM; 72 hours) shows low or no cytotoxicity to Hep-G2 cells.(In Vivo):CB2 receptor agonist 2 (compound 4g) (1 and 3 mg/kg; 1 hour) is very potent (with maximal effect being reached already at the 1 mg/kg dose) and has antihyperalgesic effects, efficacious also on the first phase of the nocifensive response and strongly reduced by AM630, a CB2-selective antagonist/inverse agonist .
-
In VitroCB2 receptor agonist 2 (compound 4g) (1 ?μM; 72 hours) has very low or no cytotoxicity to Hep-G2 cells. Cell Proliferation Assay Cell Line:Hep-G2 (Human hepatoblastoma) cells Concentration:1 ?μM Incubation Time:72 hours Result:Exhibited very low or no cytotoxicity to Hep-G2 cells.
-
In VivoCB2 receptor agonist 2 (compound 4g) (1 and 3 mg/kg; 1 hour) is very potent (with maximal effect being reached already at the 1 mg/kg dose) and has antihyperalgesic effects, efficacious also on the first phase of the nocifensive response and strongly reduced by AM630 (CB2-selective antagonist/inverse agonist) . Animal Model:Formalin injection induces a biphasic stereotypical nocifensive behavior in miceDosage:Formalin (1.25% in saline, 30 μL), 1 and 3 mg/kg CB2 receptor agonist 2, 1 mg/kg AM630, monitor every 5 minutes for 1 hour Administration:Injection in the dorsal surface of one side of the hindpaw (Formalin), i.p. (CB2 receptor agonist, AM630)Result:Elicited antihyperalgesic effects and potent (with maximal effect being reached already at the 1 mg/kg dose) and efficacious, strongly reduced by AM630.
-
Synonyms4-Quinolone-3-Carboxamide Furan CB2 Agonist | ZINC72105556
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorTrypanosoma cruzi
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1314230-75-5
-
Formula Weight488.62
-
Molecular FormulaC30H36N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC12CC3CC(CC(C3)C1)C2)C4=CN(C=5C(OC)=CC(=CC5C4=O)C=6OC=CC6)CCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Souza DCS, et al. Simplified Derivatives of Dibenzylbutyrolactone Lignans from Hydrocotyle bonariensis as Antitrypanosomal Candidates. Chem Biodivers. 2021 Oct;18(10):e2100515.
molnova catalog
related products
-
PSNCBAM-1
PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.
-
EHP-101
VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induced obesity.
-
Anandamide
Anandamide, an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55) in the central nervous system.
Cart
sales@molnova.com